pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·6h ago·1 min read
save

Ohio governor race pits former public health director against biotech entrepreneur, highlighting Covid response and health policy

Sep 22, 2026·read at STAT ↗Neutral

The Ohio gubernatorial contest features Democratic nominee Dr. Amy Acton, the former state public health director who gained national attention for Ohio’s aggressive Covid-19 response in 2020.

She is challenged by Republican candidate Vivek Ramaswamy, a biotech entrepreneur whose campaign frames the election as a test of the Midwest’s stance on health‑care costs, pandemic policy and trust in scientific expertise.

The race has become a focal point for broader debates about health policy, with campaign events highlighting local issues such as the rehabilitation of the Black River, once notorious for pollution‑related fish deformities.

Observers note that the outcome could influence how state leaders address public‑health preparedness, vaccine strategies and health‑care financing, topics of interest to pharma companies and investors.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Ohio governor’s race is a battle over Covid, health costs, and trust in science”

read at STAT ↗
757 words · retrieved 5h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LILLYROCHE
topics
Oncology2ApprovalBreast CancerVaccine

related stories

  • 2h agoBMS says goodbye to 265 New Jersey staff as reorg rolls onBioSpace
  • 20h agoSTAT+: What a vote on Grail’s cancer detection test could mean for the company, patients, and regulatorsSTAT
  • 23h agoSTAT+: Lilly’s breast cancer combo wins approvalSTAT
  • Sep 8FDA approves AstraZeneca’s Etcamah, opening ctDNA-guided treatment paradigm in breast cancerFierce Biotech
  • Sep 1Is Moderna, Merck's mRNA cancer vaccine win the start of a 'personalized medicine revolution'?Fierce Biotech